Collection-image

TOPICAL COLLECTIONS

Preclinical Models and Imaging Modalities of Tumor Microenvironment in Metastasis

Submit Abstract

Guest Editor

Sofia Sousa

Sofia Sousa

Harvard Medical School

<p>Dr. Sofia Sousa is a researcher at the Department of Experimental Medicine at Dana-Farber Cancer Institute (DFCI), Harvard Medical School. Dr. Sousa received her Ph.D., from the University of Eastern Finland under a Marie-Curie European Initial Training Network (2015), and her MSc (2009) and BSc (2008) from the Faculty of Pharmacy, University of Porto. During her PhD, she studied the role of tumor-associated macrophages (TAM) in breast cancer bone metastasis and the feasibility of TAM targeting strategies for metastasis prevention. Her research focus has since broadened, to the targeting of other bone microenvironmental cells and processes as a post-doctoral researcher in the group of Professor Clezardin at the University of Lyon (2016-2018). The importance of inter-individual immunological differences in the pathogenesis of cancer and other pathologies and the belief that the immune system is a source of disease response variability and a key aspect that should be harnessed into biomarker and personalized therapy development brought her to her current position. In Dr. Eva Guinan&rsquo;s lab, at DFCI, Dr. Sousa&rsquo;s research focuses on the use of ex vivo generated regulatory T cells for adoptive transfer to patients in different transplant and immunological imbalance settings.</p>

Collection Overview

Cancer research has focused on the cancer cell, its proliferation rates, apoptosis resistance, mutation rates, sensitivity to radio and chemotherapy. However, tumor metastatic progression involves many other cellular and molecular players, the tumor microenvironment (TME). In the battle against cancer, to improve the survival and quality of life of metastatic patients, the key cancer supporting players must be identified and targeted. For a tumor to leave its primary site, it must invade the surrounding extracellular matrix, enter the blood or lymphatic circulation, survive in circulation, extravasate at the metastatic site, start proliferating in this new tissue, and during the entire process evade the immune system. In many instances, cancer cells co-opt physiologic niches and processes to survive and even thrive in hostile environments. This is not addressed in 2D monotypic cancer cell cultures. This collection aims to highlight the latest techniques in TME research and promote “multi-cellular” interdisciplinary approaches in the field of metastasis. The collection will cover but is not limited to:

 - 3D co-culture methods of cancer and supporting cells and matrices (culture and imaging, e.g. Single Plane Illumination Microscopy)

 - tumor microenvironment metabolomic studies

- tumor vasculature imaging techniques (animal models of angiogenesis, multiphoton confocal microscopy of vascularized primary tumors and metastases)

- immune cell modulation and exploitation by cancer cells (flow cytometry methods, adoptive transfer models, intra-vital microscopy)

- circulating and disseminating tumor cell (CTC and DTC) detection methods (including methods to detect the potential of dormant DTCs to reactivate)

- humanized and patient-derived animal models of metastasis and pre-metastatic niches.

 

Articles

A Preclinical Human-Derived Autologous Gastric Cancer Organoid/Immune Cell Co-Culture Model to Predict the Efficacy of Targeted Therapies

A Preclinical Human-Derived Autologous Gastric Cancer Organoid/Immune Cell Co-Culture Model to Predict the Efficacy of Targeted Therapies

0 Views

Cited by 49

2021

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
8:40